Showing results (21-30 of 101) with videos related to
Sort By:
Pageof 11
International Journal of Radiation Oncology, Biology, Physics|April 30, 1995
Radiotherapy and androgen ablation for clinically localized high-risk prostate cancerA Pollack, G K Zagars, S KopplinUrologic Oncology|January 14, 2011
Serum testosterone is not a correlate of prostate cancer lymph node involvement, but does predict biochemical failure for lymph node positive diseaseJ F Kelly, A Pollack, G K ZagarsInternational Journal of Radiation Oncology, Biology, Physics|September 30, 1994
Influence of initial presentation on treatment outcome of clinically localized prostate cancer treated by definitive radiation therapyF B Geara, G K Zagars, A PollackCancer|May 15, 1993
Primary carcinoma of the female urethra. Results of radiation therapyA S Garden, G K Zagars, L DelclosInternational Journal of Radiation Oncology, Biology, Physics|November 1, 1995
Radiotherapy for regionally localized hormone refractory prostate cancerS P Lankford, A Pollack, G K ZagarsInternational Journal of Radiation Oncology, Biology, Physics|March 15, 1996
Malignant fibrous histiocytoma: outcome and prognostic factors following conservation surgery and radiotherapyG K Zagars, J R Mullen, A PollackSeminars in Oncology|December 22, 1999
Prostate cancer treatment with radiotherapy: maturing methods that minimize morbidityA Pollack, G K Zagars, I I RosenInternational Journal of Radiation Oncology, Biology, Physics|September 30, 1994
Serum prostate-specific antigen after radiation therapy for clinically localized prostate cancer: prognostic implicationsV S Kavadi, G K Zagars, A PollackCancer|July 15, 1994
Prostate specific antigen doubling time and disease relapse after radiotherapy for prostate cancerA Pollack, G K Zagars, V S KavadiInternational Journal of Radiation Oncology, Biology, Physics|February 25, 1999
Familial prostate cancer: outcome following radiation therapy with or without adjuvant androgen ablationM C Hanus, G K Zagars, A PollackPageof 11